RxDoctor Payments Data

Justin Newman, MD

Orthopaedic Surgery · Vail, CONPI 1932341450

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 72.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $12,822 and has fallen 65.1% since, to $4,476 in 2025.

$35,973in general payments, 2019–2025

Across 81 payments — averaging $444.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$26K
  • Vericel Corporation$5K
  • RTI Surgical, Inc$4K
  • Stryker$420
  • Covidien LP$111
  • Illuminoss Medical, Inc.$78
  • plus $257 from 6 others
$23,600in research payments, 2019–2025

Across 34 payments — averaging $694.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vericel Corporation$24K

What the payments were for

  • Consulting fees$11,39732%
  • Speaking & faculty fees$15,65344%
  • Travel & lodging$5,87516%
  • Food & beverage$3,0498%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,973 in reported general payments places this provider in the 80th percentile of 383 orthopaedic surgery providers in Colorado.

See all orthopaedic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$13,631
Medicare patients
63
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Vail

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →